APEN - Apollo Endosurgery, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 539.91M
Enterprise Value 365.69M
Trailing P/E N/A
Forward P/E 1-1.78
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.79
Price/Book (mrq)18.71
Enterprise Value/Revenue 31.29
Enterprise Value/EBITDA 6-2.62

Trading Information

Stock Price History

Beta (5Y Monthly) 1.00
52-Week Change 3-44.35%
S&P500 52-Week Change 3-10.05%
52 Week High 34.0800
52 Week Low 31.2400
50-Day Moving Average 32.3614
200-Day Moving Average 32.8069

Share Statistics

Avg Vol (3 month) 310.77k
Avg Vol (10 day) 34.7k
Shares Outstanding 520.94M
Float 8.7M
% Held by Insiders 113.98%
% Held by Institutions 166.45%
Shares Short (Mar 12, 2020) 4196.81k
Short Ratio (Mar 12, 2020) 418.58
Short % of Float (Mar 12, 2020) 4N/A
Short % of Shares Outstanding (Mar 12, 2020) 40.94%
Shares Short (prior month Feb 13, 2020) 4138.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 210:55
Last Split Date 3Dec 29, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin -54.09%
Operating Margin (ttm)-57.42%

Management Effectiveness

Return on Assets (ttm)-24.42%
Return on Equity (ttm)-177.25%

Income Statement

Revenue (ttm)50.71M
Revenue Per Share (ttm)2.35
Quarterly Revenue Growth (yoy)-21.00%
Gross Profit (ttm)25.68M
EBITDA -25.06M
Net Income Avi to Common (ttm)-27.43M
Diluted EPS (ttm)-1.2730
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)29.91M
Total Cash Per Share (mrq)1.42
Total Debt (mrq)55.05M
Total Debt/Equity (mrq)2,593.08
Current Ratio (mrq)0.97
Book Value Per Share (mrq)0.10

Cash Flow Statement

Operating Cash Flow (ttm)-25.62M
Levered Free Cash Flow (ttm)-19.56M